SciELO - Scientific Electronic Library Online

 
vol.38 número5Bypass gástrico de una sola anastomosis en pacientes con IMC < 30 kg/m2 y diabetes mellitus de tipo 2Efectos de la ingesta de lácteos enriquecidos de forma natural con selenio y omega-3 en una muestra de mujeres posmenopáusicas con síndrome metabólico: un ensayo clínico aleatorizado, triple ciego y controlado con placebo índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Nutrición Hospitalaria

versión On-line ISSN 1699-5198versión impresa ISSN 0212-1611

Nutr. Hosp. vol.38 no.5 Madrid sep./oct. 2021  Epub 24-Ene-2022

https://dx.doi.org/10.20960/nh.03602 

Original Papers

Clinical symptoms are correlated with gastrojejunal anastomosis complications only during the first year after laparoscopic Roux-en-Y gastric bypass

Los síntomas clínicos se relacionan con las complicaciones de la anastomosis gastroyeyunal solamente durante el primer año después del baipás gástrico laparoscópico

María Lapeña Rodríguez1  , Norberto Cassinello Fernández1  2  , José Martín Arévalo1  , Vicente Sanchiz Soler3  , Raquel Alfonso Ballester1  2  , Joaquín Ortega Serrano1  2 

1Endocrine and Bariatric Surgery Unit. Hospital Clínico Universitario. Valencia, Spain

2Department of Surgery. Universidad de Valencia. Valencia, Spain

3Department of Gastroenterology. Hospital Clínico Universitario. Universidad de Valencia. Valencia, Spain

Abstract

Introduction:

after laparoscopic Roux-en-Y gastric bypass (LRYGBP) many patients complain of epigastric pain or food intolerance, leading to the performance of upper gastrointestinal (UGI) endoscopy.

Objective:

this study aims to assess which symptomatology as reported by LRYGBP patients during follow-up suggested correlation with pathological findings of endoscopy, and which factors might play a role, taking the timing of symptom presentation into account.

Materials and methods:

a retrospective cohort study was performed identifying LRYGBP patients presenting with food intolerance and/or epigastric pain who had undergone endoscopy. Primary outcomes were endoscopy findings, their association with patient characteristics, and timing of symptom presentation.

Results:

of the 514 patients complaining of epigastric pain and/or food intolerance, 81 (15.6 %) underwent endoscopy. A gastrojejunostomy complication was found in 58 % of cases. All patients who complained about food intolerance and epigastric pain presented pathological findings. The only preoperative factor associated with a gastrojejunostomy complication was being a smoker (p = 0.021). Time between surgery and endoscopy was also a predictive factor for endoscopic pathological findings (p = 0.007); in cases of epigastric pain, symptom onset during the first year (median: 10 months) was related to increased risk of gastrojejunal complications (p < 0.05).

Conclusions:

endoscopies performed within one year of surgery were significantly more likely to reveal pathological findings than endoscopies performed after the first postoperative year, especially in patients experiencing epigastric pain.

Keywords: Laparoscopic Roux-en-Y gastric bypass; Gastrojejunal complication; Epigastric pain; Food intolerance; Upper gastrointestinal endoscopy

Resumen

Introducción:

tras un baipás gástrico laparoscópico en “Y de Roux” muchos pacientes refieren dolor epigástrico o intolerancia alimenticia, lo que motiva la realización de una endoscopia digestiva alta.

Objetivos:

el objetivo de este estudio es intentar establecer una relación entre la sintomatología referida por los pacientes sometidos a baipás gástrico con los hallazgos endoscópicos patológicos y conocer qué factores pueden estar implicados, considerando el momento de presentación.

Material y métodos:

estudio retrospectivo de cohortes, identificando a los pacientes sometidos a baipás gástrico laparoscópico que presentan dolor epigástrico o intolerancia alimenticia durante el seguimiento y a los que se realizó una endoscopia digestiva alta. El objetivo primario es relacionar los hallazgos endoscópicos con la sintomatología y el momento de aparición.

Resultados:

de los 514 pacientes que presentaban dolor epigástrico o intolerancia alimenticia, 81 (15,6 %) fueron sometidos a endoscopia digestiva alta. En un 58 % de los casos se encontraron complicaciones relacionadas con la gastroyeyunostomía. En todos los pacientes que presentaban simultáneamente dolor e intolerancia aparecieron hallazgos endoscópicos patológicos. El único factor preoperatorio relacionado con las complicaciones fue el hábito tabáquico (p = 0,021). El tiempo entre la cirugía y la realización de la endoscopia también fue un factor significativamente relacionado con los hallazgos endoscópicos (p = 0,007). En los casos de dolor epigástrico durante el primer año (media: 10 meses) existía un incremento del riesgo de aparición de complicaciones de la gastroyeyunostomía (p < 0,05).

Conclusiones:

las endoscopias realizadas durante el primer año postoperatorio tenían más probabilidades de presentar hallazgos patológicos, sobre todo en los pacientes afectos de dolor epigástrico.

Palabras clave: Baipás gástrico laparoscópcio en “Y de Roux”; Complicaciones; Gastroyeyunostomía; Dolor epigástrico; Intolerancia alimenticia; Endoscopia digestiva alta

INTRODUCTION

Bariatric surgery is the only therapy with demonstrated benefits in terms of excess weight loss and improvement or resolution of weight-related comorbidities in morbid obese patients (1,2). Laparoscopic Roux-en-Y gastric bypass (LRYGBP) is the most frequently performed among all applied bariatric procedures, and has become the second commonest bariatric procedure worldwide (39.6 %) after sleeve gastrectomy (45.9 %) (3).

Perioperative complications have been reduced with the deve­lopment and widespread use of advanced laparoscopic techniques, accreditation programs, and specialized bariatric surgery units (4). However, medium or long-term complications related to gastrojejunal anastomosis such as stomal stenosis or anastomotic ulcers are well-known complications after LRYGBP that occur in 3-31 % and 1-16 % of patients, respectively, involving different local (mechanical or hand-sewn sutures, Helicobacter pylori presence) and systemic factors (smoking habits or type 2 diabetes mellitus [T2DM]) (5).

Patient complaints during follow-up remain challenging for the surgeon due to the sometimes confusing and vague nature of symptomatology. A barium swallow or upper gastrointestinal (UGI) endoscopy are usually performed when patients experience treatment-resistant gastrointestinal symptoms like epigastric pain or food intolerance during follow-up, but any correlation between those symptoms and endoscopic findings is not well stablished.

The aim of this study was to assess what kind of sympto­matology referred by LRYGBP patients during follow-up suggested correlation with pathological findings during endoscopy, and which factors might play a role, taking the time frame into account.

MATERIAL AND METHODS

A retrospective review was conducted of 514 consecutive primary LRYGBPs carried out between January 2008 and December 2018 at our center. All surgeries were performed by three experienced surgeons at the bariatric surgery unit. Exclusion criteria included other techniques (sleeve gastrectomy, one-anastomosis gastric bypass) or revisional procedures. Patients with complications needing reintervention for leakage or other causes were also excluded from the study.

Clinical assessment included gender, age, body mass index (BMI), comorbidities (T2DM) and smoking habit. Liver/gallbladder ultrasound and UGI endoscopy were performed in all patients. Preoperative UGI endoscopic findings were classed as normal, erythematous gastritis or ulcer. Helicobacter pylori eradication was not routinely performed.

LRYGBP was performed by creating a 30-mL gastric pouch over a 36-Fr bougie. Gastro-jejunal anastomosis was created in a side-to-side mechanical fashion (linear stapler, 45 mm in length) with running 2/0 monofilament suture closure of the gastrojejunostomy. Alimentary limb length was 150-200 cm in an antecolic, antegastric route. Biliary limb was 60-80 cm long. Jejunum-jejunal anastomosis was also mechanical side-to-side with a linear stapler.

During follow-up, symptoms were recorded as epigastric pain, food intolerance or both, and proton-pump inhibitors, sucralfate or prokinetic treatment were started empirically. Endoscopy was performed in patients who reported treatment-resistant gastrointestinal symptoms. The time between surgery and endoscopy was reviewed.

Normal postoperative endoscopic findings were defined by no findings or by superficial gastritis. Stomal stenosis of the gastro-jejunal anastomosis was defined as a diameter smaller than 10 mm, not allowing passage of the scope, requiring posterior dilatation. Anastomotic ulcer was defined as any ulceration of the mucosa at the level of the gastrojejunostomy.

Data were obtained from clinical records and the endoscopy database, and analyzed anonymously. An informed consent was provided before surgery and endoscopy.

STATISTICAL ANALYSIS

The statistical analysis was performed using the IMB SPSS Statistics 25 software (IBM Corp., Armonk, NY). Quantitative variables are presented as means (standard deviations), and qualitative variables as percentages (range). Group comparisons were made using the Chi-square or Fisher's exact test, as appropriate. Mean comparisons were made using Student's t-test. For non-parametric variables, the Mann-Whitney test was employed. A p-value < 0.05 was considered statistically significant.

RESULTS

During the period between January 2008 and December 2018 a total of 641 patients underwent bariatric surgery in our center, of which 514 were primary LRYGBPs and were included in the review.

During postoperative follow-up 81 patients (15.6 %) who com­plained of epigastric pain and/or food intolerance underwent endoscopy (66 women and 15 men, mean age: 44.8 ± 8.82 years, with a preoperative BMI of 46.2 ± 6.1 kg/m2). Median time between surgery and endoscopy was 8 months (Table I).

Table I.  Demographic data 

*Mean ± SD. †Median (minimum, maximum). BMI: body mass index.

In this symptomatic patients group, endoscopy diagnosed 47 (58 %) cases with a gastrojejunostomy complication, while in 34 cases (42 %) no pathological findings were revealed.

When endoscopic findings were analyzed (Table II), the commonest symptoms in patients with a gastrojejunal complication (ulcer or stenosis) were food intolerance (54.5 %), epigastric pain (34.1 %), or both (11.4 %). In the patient group without abnormal findings, self-reported symptomatology included food intolerance in 55.9 % and epigastric pain in 44.1 %.

Table II.  Symptoms and endoscopic findings 

Table II also shows the analysis of clinical symptoms. A total of 45 patients (55.6 %) presented food intolerance. In 19 ca­ses (42.2 %) no pathological findings were observed, but ulcer was observed in 10 cases and stenosis in 16. Epigastric pain was present in 31 patients (38.3 %), 15 without pathological findings and 16 evidencing ulcer. Only 5 patients (6.2 %) reported food intolerance and pain, but all these patients presented a complication: 4 had ulcer and 1 stenosis.

There were 32 smokers and 49 non-smokers in the cohort of 81 patients. Gastrojejunal complications were observed in 75 % of smokers, while only 46.9 % in the non-smoker group had this condition (p = 0.021). No significant differences in complications were found between T2DM patients (47.6 %) and non-diabetics (61.7 %). Furthermore, preoperative endoscopic findings were not significantly correlated with pathological postoperative findings (p = 0.253).

When analyzing the time elapsed from LRYGBP to endoscopy, median lengtht was 7 months in patients with gastrojejunal complications, and 15 months in patients without pathological findings (p = 0.007). In the group with epigastric pain and the subsequent ulcer patient subset, endoscopy was performed more frequently during the first postoperative year (median 10 months, p < 0.05). Non-significant differences were found in the food intolerance subgroup (p = 0.139) (Table III).

Table III.  Comparison of patients with normal and pathologic endoscopic findings 

*Mean ± SD. †Median (minimum, maximum).

DISCUSSION

The goal of our study was to assess whether any preoperative factors, clinical symptoms, or time intervals suggested a higher risk for medium- or long-term complications as subsequently confirmed by postoperative endoscopy in patients submitted to LRYGBP. Patient complaints after bariatric surgery are sometimes confusing and unspecific. Nausea, vomiting, and epigastric pain are the most common symptoms after bariatric surgery, frequently associated with dietary non-adherence or food impaction due to surgery-induced anatomical and functional changes.

The pathophysiology underlying gastrojejunal complications (stenosis or ulcer) has not been well established. Ischemia, tobacco use, nonsteroidal anti-inflammatory drugs (NSAIDs), pouch size, and T2DM are among the predisposing factors. The technique used to create the gastrojejunal anastomosis (circular or linear stapler, absorbable on non-absorbable sutures) might also be an important factor in the development of late anastomotic complications.

UGI endoscopies should be considered in patients with persistent symptoms despite dietary and/or lifestyle changes or nutrition counseling. Our results show that 58 % of cases with symptomatology suggestive of a postoperative complication revealed some sort of pathological findings during endoscopy. Although normal UGI endoscopy results have been reported as the most common postoperative finding in these patients, other studies nonetheless concur with our findings (6,7).

Self-reported symptomatology when these complications appear is typically epigastric pain or food intolerance, also found in our study (8). Our results showed that food intolerance was the most common symptom (56 %): almost 60 % of these cases evidenced a complication, and although stenosis was more frequent (16/45), the presence of ulcers (10/45) was also considerable. In cases of epigastric pain (38 %) ulcer was observed in almost 50 %. Also, a small proportion of cases (6 %) presented epigastric pain and food intolerance, but interestingly, all of them presented one of the two anastomotic complications studied.

Gastrojejunal stenosis and ulcers are well-known complications after LRYGBP, with an estimated incidence between 3 % and 27 %, and 0.6 % and 25 % of cases, respectively (9,10). A series investigating postoperative symptom management, published by Lee et al., reported normal findings in 43 % of cases, anastomotic ulcer in 27 %, and stomal stenosis in 19 % (11). These findings agree with those reported in our series, which detected normal findings (42 %), anastomotic ulcer (37 %), and stomal stenosis (21 %) in symptomatic patients who underwent UGI endoscopy.

The pathogenesis of anastomotic ulcers is unclear. Azagury et al. (12) performed a study in 103 patients with marginal ulcers after a Roux-en-Y gastric bypass, finding that diabetes, smoking, and gastric pouch length were significantly associated with marginal ulcer formation. These results were in line with other subsequent publications that showed smoking as a risk factor (13,14). In our study smoker patients presented a higher risk of complications than nonsmokers (52 % vs. 23.5 %, p = 0.021). In T2DM patients no major differences were discovered by our study.

The role of H. pylori presence is ill-defined, and the need for H. pylori screening and eradication before surgery is still controversial. Some authors like Rawlins et al. find no support for the assumption that H. pylori could be involved in the development of complications (15). Moreover, other studies showed that obese patients presented a significantly lower rate of H. pylori infection eradication when compared to controls with the triple therapy (16). Given the lack of consistent evidence, we do not routinely eradicate H. pylori.

As regards the relationship of timing between surgery and endoscopy, Huang et al. found a trend toward a shorter interval between surgery and endoscopy in patients with abnormal endoscopy as compared with those with normal endoscopy (p = 0.09) (17). In our study major differences were identified between pathological and normal endoscopies, with shorter times in cases with pathologic findings (p = 0.007). In patients experiencing epigastric pain, the longer the interval from surgery, the greater the likelihood of normal endoscopy. Patients who experienced epigastric pain during the first postoperative year had a higher rate of complications in the gastrojejunal anastomosis (p < 0.05).

In summary, the present study confirms that upper gastrointestinal endoscopy is an important diagnostic tool in LRYGBP patients with certain postoperative symptoms such as epigastric pain or food intolerance. In our series, the most common (almost 60 %) endoscopic finding was a pathological cause (stenosis or ulcer). Endoscopies performed within one year after surgery were significantly more likely to have pathological findings than those conducted after this first postoperative year, especially in patients suffering from epigastric pain.

This study has certain limitations. Firstly, it is a retrospective study involving a considerable patient sample but with a long follow-up, which could entail certain loss of patients over the study period. Secondly, intraoperative factors not comparable in this study (as only side-to-side mechanical anastomoses were performed) may be involved. Additionally, patient symptomatology is mostly unspecific and time of presentation can vary substantially. Finally, postoperative endoscopy was not routinely performed in all LRYGBP, which ruled out evaluating complications in asymptomatic patients.

Nowadays, perioperative protocols in bariatric surgery depend on many factors (national guidelines, regional associations, or even surgeon preferences), and there is no consensus on whether complementary tests should be requested during postoperative follow-up. The diagnostic method is usually chosen based on high clinical suspicion. Our data suggests that the timing of symptom presentation could inform decision-making and triaging as regards endoscopy, thus minimizing unnecessary invasive and costly procedures.

In the future, it would be important to carry out prospective studies to better identify groups at risk of developing complications, making it possible to establish endoscopic follow-up protocols and earlier diagnoses for these individuals. On the other hand, since ulcer is the most frequent pathological finding, it would be interesting to evaluate a PPI treatment during the first year after surgery, since it has been seen that one of the most important predisposing factors is acid production by the gastric reservoir.

Acknowledgements:

we thank the INCLIVA translation service for their help in the revision of the English translation.

REFERENCES

1. Puzziferri N, Roshek TB, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery:a systematic review. JAMA 2014;312(9):934-42. DOI:10.1001/jama.2014.10706 [ Links ]

2. World Health Organization. Obesity and Overweight Fact Sheet [Internet];2020. Available from:https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweightLinks ]

3. Angrisani L, Santonicola A, Iovino P, Vitiello A, Zundel N, Buchwald H, et al. Bariatric Surgery and Endoluminal Procedures:IFSO Worldwide Survey 2014. Obes Surg 2017;27(9):2279-89. DOI:10.1007/s11695-017-2666-x [ Links ]

4. Sjöström L. Bariatric surgery and reduction in morbidity and mortality:experiences from the SOS study. Int J Obes (Lond) 2008;32(Suppl 7):S93-7. DOI:10.1038/ijo.2008.244 [ Links ]

5. Vasquez JC, Wayne Overby D, Farrell TM. Fewer gastrojejunostomy strictures and marginal ulcers with absorbable suture. Surg Endosc 2009;23(9):2011-5. DOI:10.1007/s00464-008-0220-6 [ Links ]

6. Yang CS, Lee WJ, Wang HH, Huang SP, Lin JT, Wu MS. Spectrum of endoscopic findings and therapy in patients with upper gastrointestinal symptoms after laparoscopic bariatric surgery. Obes Surg 2006;16(9):1232-7. DOI:10.1381/096089206778392176 [ Links ]

7. Quadros LG, Kaiser Jr. RL, Galvão Neto MP, Campos JM, Santana MF, Ferraz AAB. Long-term postoperative endoscopic findings after gastric bypass procedure:a co-occurrence analysis. Arq Gastroenterol 2016;53(4):273-7. DOI:10.1590/S0004-28032016000400012 [ Links ]

8. Boerlage TCC, Wolvers PJD, Bruin SC, Huibregtse IL, Voermans RP, Fockens P, et al.. Upper endoscopy after Roux-en-Y gastric bypass:diagnostic yield and factors associated with relevant findings. Surg Obes Relat Dis 2020;16(7):868-76. DOI:10.1016/j.soard.2020.03.001 [ Links ]

9. Da Costa M, Mata A, Espinós J, Vila V, Roca JM, TurróJ, et al.Endoscopic dilation of gastrojejunal anastomotic strictures after laparoscopic gastric bypass. Predictors of initial failure. Obes Surg 2011;21(1):36-41. DOI:10.1007/s11695-010-0154-7 [ Links ]

10. Palermo M, Acquafresca PA, Rogula T, Duza GE, Serra E. Late surgical complications after gastric by-pass:a literature review. Arq Bras Cir Dig 2015;28(2):139-43. DOI:10.1590/S0102-67202015000200014 [ Links ]

11. Lee JK, Van Dam J, Morton JM, Curet M, Banerjee S. Endoscopy is accurate, safe, and effective in the assessment and management of complications following gastric bypass surgery. Am J Gastroenterol 2009;104(3):575-82. DOI:10.1038/ajg.2008.102 [ Links ]

12. Azagury DE, Abu Dayyeh BK, Greenwalt IT, Thompson CC. Marginal ulceration after Roux-en-Y gastric bypass surgery:characteristics, risk factors, treatment, and outcomes. Endoscopy 2011;43(11):950-4. DOI:10.1055/s-0030-1256951 [ Links ]

13. Coblijn UK, Lagarde SM, de Castro SMM, Kuiken SD, van Wagensveld BA. Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass:incidence, risk factors and management. Obes Surg 2015;25:805-11. DOI:10.1007/s11695-014-1482-9 [ Links ]

14. Coblijn UK, Goucham AB, Lagarde SM, Kuiken SD, van Wagensveld BA. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation:a systematic review. Obes Surg 2014;24:299-309. DOI:10.1007/s11695-013-1118-5 [ Links ]

15. Rawlins L, Rawlins MP, Brown CC, Schumacher DL. Effect of Helicobacter pylori on marginal ulcer and stomal stenosis after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2013;9(5):760-4. DOI:10.1016/j.soard.2012.06.012 [ Links ]

16. Abdullahi M, Annibale B, Capoccia D, Tari R, Lahner E, Osborn J, et al. The eradication of Helicobacter pylori is affected by body mass index (BMI). Obes Surg 2008;18(11):1450-4. DOI:10.1007/s11695-008-9477-z [ Links ]

17. Huang CS, Forse RA, Jacobson BC, Farraye FA. Endoscopic findings and their clinical correlations in patients with symptoms after gastric bypass surgery. Gastrointest Endosc 2003;58(6):859-66. DOI:10.1016/s0016-5107(03)02310-1 [ Links ]

Funding:this study was not supported by any funds.

Received: March 08, 2021; Accepted: April 27, 2021

Correspondence: Norberto Cassinello Fernández. Servicio de Cirugía General. Hospital Clínico Universitario. Av. de Blasco Ibáñez, 17. 46010 Valencia, Spain e-mail: cassinello73@hotmail.com

Conflicts of interest:

the authors declare that they have no conflicts of interest.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License